<DOC>
	<DOC>NCT01006993</DOC>
	<brief_summary>To assess the safety and feasibility of using the NeuroFlo catheter to treat acute ischemic stroke patients following administration of intravenous tPA.</brief_summary>
	<brief_title>Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Ischemic stroke NIHSS between 522 Persistent clinical deficits following administration of rtPA Planned thrombectomy Aortic pathology Severe heart disease Other conditions the doctor will assess</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>